Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
Key insights:
- Fertilis technology offers improvement in IVF success rates and a faster time to pregnancy by removing an entire cycle.
- The technology involves an artificial cell culture environment when the conditions can be precisely controlled to mimic nature, and ensure the best outcomes.
- Fertilis is expanding into potential treatments in regenerative medicine that require stem cell research such as; vision loss and cystic fibrosis.
From business idea to innovative product